Log in to search using one of your social media accounts:

 

UNICEF USAVoice: Ridding The World Of Rotavirus, One Dose At A Time
See how far we've come in the fight against rotavirus, the deadliest diarrheal disease in children under five. But not every child is protected yet. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 5, 2018 Category: Pharmaceuticals Authors: Maryanne Murray Buechner, UNICEF USA Tags: unicefusa Source Type: news

Experimental Rotavirus Vaccine More Effective When Started at Birth Experimental Rotavirus Vaccine More Effective When Started at Birth
An experimental oral rotavirus vaccine, when given at birth and in two subsequent doses, can reduce the rate of severe and potentially deadly diarrhea by 75%, according to new study conducted among Indonesian babies.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 22, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Africa:Vaccine for Infant Diarrhoeal Disease Gets WHO Approval
[East African] The World Health Organisation has approved the manufacture of a new vaccine aimed at preventing a diarrhoeal disease spread by rotavirus among infants and young children. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 6, 2018 Category: African Health Source Type: news

Uganda:Uganda Introduces New Rotavirus Vaccine for Infants
[Monitor] Uganda has introduced a new drug to combat Rotavirus and other related diseases among the infants in the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 30, 2018 Category: African Health Source Type: news

Rotavirus vaccine could reduce UK health inequalities, new study suggests
(University of Liverpool) New research led by the University of Liverpool has found that childhood vaccination against rotavirus has greatest benefit in the most deprived communities and could contribute to reducing health inequalities in the UK. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 29, 2018 Category: Infectious Diseases Source Type: news

Researchers gain new insight into how the intestine repairs itself
(Baylor College of Medicine) Researchers propose that, contrary to the current thinking, how the intestine repairs itself seems to depend on the type of damage, and they found that triggers that were previously thought to be unimportant are actually essential for repairing rotavirus-caused injury. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2018 Category: International Medicine & Public Health Source Type: news

WHO awards prequalification to Bharat Bio ’s Rotavirus vaccine
The vaccine to prevent infant deaths and hospitalisations due to rotavirus diarrhoea was launched by Prime Minister Narendra Modi in March 2015. (Source: The Economic Times)
Source: The Economic Times - January 26, 2018 Category: Consumer Health News Source Type: news

Tanzania:Who's Rotavac Vaccine Pre-Qualification to Step Up Diarrhoea Fight
[Daily News] IMMUNISATION against diarrhoea for children under five years in Tanzania and globally has received yet another boost, thanks to prequalification by the World Health Organisation (WHO), of an additional rotavirus vaccine dubbed 'Rotavac', which is produced by India's Bharat Biotech. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 25, 2018 Category: African Health Source Type: news

India-made rotavirus vaccine achieves World Health Organization prequalification
(PATH) Indian vaccine manufacturer Bharat Biotech has received prequalification from the WHO for their oral rotavirus vaccine, ROTAVAC. The vaccine will now be available for procurement by United Nations agencies and Gavi for use in low-resource countries. PATH worked with the Indian Department of Biotechnology, the Society for Applied Studies, and Bharat Biotech on the clinical trials that demonstrated the safety and efficacy of the vaccine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 24, 2018 Category: International Medicine & Public Health Source Type: news

Rotavirus
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 22, 2018 Category: General Medicine Source Type: news

Two-thirds of Eligible High-risk Infants Not Vaccinated Against Rotavirus in Hospital Two-thirds of Eligible High-risk Infants Not Vaccinated Against Rotavirus in Hospital
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 7, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Increased rotavirus vaccination improves quality of care
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2017 Category: Drugs & Pharmacology Source Type: news

Rotavirus vaccine potentially cost  effective in Afghanistan
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2017 Category: Drugs & Pharmacology Source Type: news

Global Routine Vaccination Coverage, 2016
Global coverage with the third dose of diphtheria and tetanus toxoids and pertussis-containing vaccine, the third dose of polio vaccine, and first dose of measles. Among new or underused vaccines, global coverage increased during 2010-2016 for completed vaccine series against rotavirus (8% to 25%), Streptococcus pneumoniae (11% to 42%), rubella (35% to 47%), Haemophilus influenzae type B (42% to 70%) and hepatitis B vaccine (74% to 84%). containing vaccine coverage has remained unchanged at 84%-86% since 2010. (Source: PHPartners.org)
Source: PHPartners.org - November 16, 2017 Category: International Medicine & Public Health Source Type: news

Vaccination Coverage Among Children Aged 19-35 Months - United States, 2016
Coverage with most recommended vaccines remained stable and high in 2016; coverage was ≥90% for polio, measles, mumps, and rubella, varicella, and hepatitis B vaccines, and lowest (61%-74%) for hepatitis A, the birth dose of hepatitis B, and rotavirus vaccines, and the combined 7-vaccine series. (Source: PHPartners.org)
Source: PHPartners.org - November 3, 2017 Category: International Medicine & Public Health Source Type: news

Implementation of Rotavirus Surveillance and Vaccine Introduction — World Health Organization African Region, 2007–2016
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - November 2, 2017 Category: American Health Source Type: news

ORV 116E cost effective for prevention of rotavirus in India
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2017 Category: Drugs & Pharmacology Source Type: news

What Causes Hypernatremia?
Discussion Hypernatremia is a serum sodium of> 150 mEq/L. Basic causes are too much sodium or too little free water. If body weight is normal or increased, there is an increase in total body sodium without an appropriate increase in total body water. Normally when the serum sodium is increased there is transient hypertonicity of the plasma which causes the thirst center to be stimulated and antidiuretic hormone (ADH) to be released. The thirst center tells the person to drink more water and ADH causes the kidney to retain free water. This normally will allow the plasma tonicity to go back to normal. Treatment is by tr...
Source: PediatricEducation.org - October 30, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

New vaccine shows significant efficacy against rotavirus
A Phase 3 clinical trial in India of the rotavirus vaccine BRV-PV known as ROTASIIL shows the vaccine is safe and effective against severe rotavirus. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 26, 2017 Category: Consumer Health News Source Type: news

Serum Institute's vaccine demonstrates significant efficacy against severe rotavirus
(PATH) Results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd.'s rotavirus vaccine BRV-PV (known as ROTASIIL ® ) were published in the journal Vaccine. The study showed the vaccine to be safe, well tolerated, and to provide significant efficacy against severe rotavirus gastroenteritis. In 2013, an estimated 47,100 rotavirus deaths occurred in India, 22 percent of all rotavirus deaths that occurred globally. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 26, 2017 Category: Infectious Diseases Source Type: news

Rotavirus vaccines reduce diarrhea hospitalizations in kids
A recent study found the rotavirus vaccine has reduced hospitalizations of children in the United States by more than 380,000 between 2008 and 2013. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 10, 2017 Category: Consumer Health News Source Type: news

Rotavirus Vaccine Cut Kids' Hospitalization, Medical Costs
Virus a common cause of diarrhea among children, study authors reportSource: HealthDay Related MedlinePlus Pages: Diarrhea, Infant and Newborn Care, Rotavirus Infections (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 10, 2017 Category: Consumer Health News Source Type: news

Rotavirus Vaccine Cut Kids' Hospitalization, Medical Costs
WEDNESDAY, Aug. 9, 2017 -- Hundreds of thousands of cases of diarrhea in young children have been prevented since routine vaccination against rotavirus began in the United States a decade ago, a new study shows. That has translated into a savings of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 10, 2017 Category: General Medicine Source Type: news

Rotavirus Vaccine Cut Kids' Hospitalization, Medical Costs
Title: Rotavirus Vaccine Cut Kids' Hospitalization, Medical CostsCategory: Health NewsCreated: 8/10/2017 12:00:00 AMLast Editorial Review: 8/10/2017 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - August 10, 2017 Category: Pediatrics Source Type: news

Rotavirus vaccines continue to reduce diarrhea hospitalizations, medical costs in US kids
(Pediatric Infectious Diseases Society) Following the introduction of routine childhood vaccination against rotavirus, a common cause of diarrheal illness, more than 380,000 children avoided hospitalization for diarrhea from 2008 to 2013 in the US, thus saving an estimated $1.2 billion in direct medical costs. The estimates, from a new study published in the Journal of the Pediatric Infectious Diseases Society, provide additional evidence for the substantial impact of routine rotavirus vaccination. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 10, 2017 Category: Infectious Diseases Source Type: news

Papers of note in Nature 546 (7660)
This week’s articles highlight a mechanism by which melanoma cells prepare the metastatic niche, intestinal defense against rotavirus, and immune tolerance in the human fetus. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - July 4, 2017 Category: Science Authors: VanHook, A. M. Tags: STKE Editors ' Choice Source Type: news

Rotavirus vaccination cost effective in Bangladesh
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2017 Category: Drugs & Pharmacology Source Type: news

Study pinpoints protein key to fighting a common intestinal illness
Rotavirus is the most common cause of diarrhea in infants and young children worldwide. It is highly infectious and potentially deadly. The virus, which has evolved strategies to evade the immune system, is the focus of new research lead by immunologist Richard Flavell and published in Nature. (Source: Yale Science and Health News)
Source: Yale Science and Health News - June 21, 2017 Category: Universities & Medical Training Tags: Yale News Source Type: news

VACCINE HOAX unveiled as rigorous scientific study finds NO reduction in measles, mumps, rubella, influenza or rotavirus among vaccinated children
(Natural News) The measles, mumps, and rubella (MMR) vaccine controversy started with the 1998 publication of a research paper in the medical journal The Lancet. Former gastroenterologist Dr. Andrew Wakefield and his team found a link between the MMR vaccine and inflammatory bowel disease. The paper was eventually retracted under the weight of an organized... (Source: NaturalNews.com)
Source: NaturalNews.com - May 30, 2017 Category: Consumer Health News Source Type: news

NCBI ’s Virus Variation Resource Enhancements Include Standardized Search Criteria
NCBI ’s Virus Variation resource makes it easy to find genome and protein sequences for a number of viruses – no more stumbling through multiple synonyms to find what you need. Now you can search using standardized biological criteria and intuitive…Continue reading→ (Source: NCBI Announcements)
Source: NCBI Announcements - May 30, 2017 Category: Databases & Libraries Authors: NCBI Staff Tags: What's New Dengue Ebolavirus influenza MERS Rotavirus variation viruses West Nile Zika Source Type: news

This World Health Organization Leadership Election Is Crucial, And It's Getting Ugly
There is less than a week to go in the race to be the next Director-General of the World Health Organization. And given the WHO’s recent mis-steps, especially with regard to Ebola, this is a crucial election. Unfortunately, the race just got terribly nasty with its own “dirty tricks.” The race has boiled down to a contest between Dr. Tedros Adhanom Ghebreyesus of Ethiopia and Dr. David Nabarro of Britain. Tedros, as he is universally known, is the former minister of health and foreign minister of Ethiopia.  Under his leadership, Ethiopia trained and deployed approximately 40,000 community health...
Source: Healthy Living - The Huffington Post - May 19, 2017 Category: Consumer Health News Source Type: news

Your NEJM Group Today: Healthcare Needs Data Science Strategy / Low-Cost Rotavirus Vaccine / New York Hematologist-Oncologist Opportunity (FREE)
By the Editors Have a look at today's featured articles from NEJM Group:NEJM Catalyst: Data science strategy can help … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 27, 2017 Category: Primary Care Source Type: news

Africa health: Rotavirus vaccine could save 500,000 children a year
The Indian vaccine, which protects against gastroenteritis caused by rotavirus, was tested in Niger. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 23, 2017 Category: Consumer Health News Source Type: news

Africa: Cheap, Heat-Proof Rotavirus Vaccine 'Game Changer' for African Children
[Thomson Reuters Foundation] Dakar -Rotavirus is the leading cause of severe diarrhoea and kills an estimated 1,300 children a day, mostly in Africa An inexpensive, heat-proof vaccine could mark a turning point in expanding resistance to the diarrhoea-causing rotavirus infection across sub-Saharan Africa, medical aid agency Medecins Sans Frontieres said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 23, 2017 Category: African Health Source Type: news

Breaking The Cold Chain: New Vaccine Doesn't Need Refrigeration
The world is on the verge of having the first vaccine against rotavirus that can stand up to hot African sun -- and save thousands of children's lives. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 23, 2017 Category: Pharmaceuticals Authors: Tara Haelle, Contributor Source Type: news

New, Cheaper, and Heat-Stable Rotavirus Vaccine Could Prevent Thousands of Childhood Deaths
A new, heat-stable vaccine is safe and effective against rotavirus, according to results of a recent MSF vaccine trial in Niger.Language English (Source: MSF News)
Source: MSF News - March 22, 2017 Category: Global & Universal Authors: Jess Brown Source Type: news

New Vaccine Could Slow Disease That Kills 600 Children a Day
A lower-cost vaccine provides strong protection against rotavirus, a diarrheal disease, and could be particularly useful in poorer countries, researchers said. (Source: NYT Health)
Source: NYT Health - March 22, 2017 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Vaccination and Immunization Third World and Developing Countries Diarrhea Rotaviruses Doctors Without Borders Gavi, the Vaccine Alliance New England Journal of Medicine Serum Institute of India World Health Organization Gates, Bill and Source Type: news

Rotavirus vaccine could save lives of almost 500,000 children a year
Positive outcome of trials in Niger fuels hope that vaccine can protect children in sub-Saharan Africa and beyond from infection that causes often fatal diarrhoeaA vaccine capable of enduring scorching temperatures for months at a time could strike a decisive blow in the fight against rotavirus, preventing nearly half a million children around the world from dying of diarrhoea each year.M édecins Sans Frontières (MSF) has hailed successful trials of the BRV-PV vaccine in Niger as a “game changer” in tackling rotavirus infection, which is the leading cause of severe diarrhoea globally and claims th...
Source: Guardian Unlimited Science - March 22, 2017 Category: Science Authors: Kate Hodal Tags: Global health Global development Vaccines and immunisation Society Africa World news Infectious diseases Science Source Type: news

Oral Rotavirus Vax Shows Efficacy in African Kids (CME/CE)
(MedPage Today) -- No significant safety signals seen with three-dose vaccine (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 22, 2017 Category: American Health Source Type: news

New, Cheaper, and Heat-Stable Rotavirus Vaccine Could Prevent Thousands of Childhood Deaths
Press releaseNew, Cheaper, and Heat-Stable Rotavirus Vaccine Could Prevent Thousands of Childhood DeathsMarch 22, 2017NEW YORK, MARCH 22, 2017—A new, heat-stable vaccine is safe and effective against rotavirus, according to results of a recent Doctors Without Borders/Médecins Sans Frontiéres vaccine trial in Niger, published in theNew England Journal of MedicineThursday. (Source: MSF News)
Source: MSF News - March 22, 2017 Category: Global & Universal Authors: Brienne Prusak Source Type: news

New low-cost rotavirus vaccine could reduce disease burden in developing countries
(Harvard T.H. Chan School of Public Health) A new vaccine for rotavirus was found to be 66.7 percent effective in preventing severe gastroenteritis caused by the virus, according to a new study from researchers at Harvard T.H. Chan School of Public Health and Epicentre, Paris. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 22, 2017 Category: Infectious Diseases Source Type: news

Crazed conventional doctor says you can safely administer 10,000 vaccines to infants at one time
(Natural News) Paul Offit says you can safely administer 10,000 vaccines to infants at once. But he also profits from the patent he holds for the Rotateq vaccine. What’s wrong with this picture?  (Article by Green Med Info Research Group, republished from GreenMedInfo.com) Dr. Paul Offit is a pediatrician who co-invented a rotavirus vaccine (trade name... (Source: NaturalNews.com)
Source: NaturalNews.com - March 9, 2017 Category: Consumer Health News Source Type: news

RotaTeq (Rotavirus Vaccine, Live, Oral, Pentavalent) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 8, 2017 Category: Drugs & Pharmacology Source Type: news

Rotarix (Rotavirus Vaccine, Live, Oral Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 8, 2017 Category: Drugs & Pharmacology Source Type: news

Human rotavirus manipulates immune response to maintain infection
Using a laboratory model of the human gut, scientists have found that although human rotavirus does not succeed at preventing initial steps of the defense response, it is able to minimize subsequent steps that could stop its growth. Using a model of the live human gut, the scientists showed strategies to counter the viral response. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 24, 2017 Category: Science Source Type: news

Human rotavirus manipulates immune response to maintain infection
(Baylor College of Medicine) Using a laboratory model of the human gut, scientists at Baylor College of Medicine and Johns Hopkins University School of Medicine have found that although human rotavirus does not succeed at preventing initial steps of the defense response, it is able to minimize subsequent steps that could stop its growth. Using a model of the live human gut, the scientists showed strategies to counter the viral response. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 24, 2017 Category: Infectious Diseases Source Type: news

New insights in genetic defect allow prevention of fatal illnesses in children
A team of scientists was able to characterize a new genetic immunodeficiency resulting from a mutation in a gene named STAT2. This mutation causes patients to be extremely vulnerable to normally mild childhood illnesses such as rotavirus and enterovirus. The comprehensive analysis of the genetic defect allows clinicians to provide children with the proper therapies before illnesses prove fatal. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 18, 2017 Category: Science Source Type: news

These Numbers Show Just How Safe Vaccines Are
Anti-vaccine advocate Robert F. Kennedy Jr. said that President-elect Donald Trump asked him to lead a new government commission on vaccine safety. But science on this issue is already clear; numerous studies show that vaccines are safe and effective, and that serious side effects are rare. On Jan. 10, Kennedy met with the president-elect at Trump Tower, and later told reporters about the new commission. However, the Trump administration did not confirm that such a commission was in the works. A spokesperson for Trump said only that the president-elect was “exploring the possibility of forming a committee on autism,&...
Source: Healthy Living - The Huffington Post - January 17, 2017 Category: Consumer Health News Source Type: news